HIV/AIDS-Related Cancer
HIV-1 disease length and not immune status is a risk factor for anal carcinoma development
Published in AIDS Weekly, January 2nd, 2006
According to a study from the United States, "The anal epithelium is subject to dysplastic change in patients with human immunodeficiency virus (HIV). We sought to determine if the duration of HIV disease or the patient's immune status were associated with the development of anal carcinoma. HIV-positive patients diagnosed with anal neoplasms were reviewed."
"Statistical analysis was performed via an unpaired Student t test and the Fisher exact test. Fourteen patients were identified, 7 with anal intraepithelial neoplasms (group 1) and 7 with anal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-02)
More Articles from AIDS Weekly
- Disease Associations
HIV-infected nonimmune adults are at increased risk of severe malaria - HIV/AIDS HAART
Replication-competent HIV persists in patients with uninterrupted HAART - HIV/AIDS Research
Health Canada grants approval for first-in-man clinical trial of treatment of drug resistant HIV - HIV/AIDS Therapy
Interruptions of shorter periods are unlikely to allow restoration of mitochondrial DNA - Diet & Nutrition
Trial final results show Resurgex reduces oxidative stress and enhances performance - Disease Associations
HIV/AIDS does not influence circulating leukocyte counts during measles infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
